Positive 5-year data argue for early identification and treatment of symptomatic patients in whom transcatheter edge-to-edge repair is appropriate for heart failure with secondary mitral regurgitation.
Contour or Clip? REDUCE-FMR Suggests Broadened Options for Percutaneous Mitral Valve Therapy
Encouraging findings from this sham-controlled study of the Carillon device for transvenous mitral annuloplasty in functional mitral regurgitation pique interest in the large ongoing CARILLON trial.
MitraClip Drives Down Deaths, HF Hospitalization in Secondary Mitral Regurgitation
The COAPT trial finds transcatheter mitral valve repair to be safe and highly effective in a setting with no good treatment options: symptomatic mitral regurgitation secondary to heart failure.
Percutaneous Mending of the Mitral Valve: A Status Report on Challenges and Progress
The mitral valve poses anatomic challenges to transcatheter treatment that the aortic valve doesn’t. Here’s a glimpse into six ongoing studies designed to overcome them.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy